Cerity Partners
HRMY icon

Cerity Partners’s Harmony Biosciences HRMY Stock Holding History

Cerity Partners’s Portfolio HRMY Stock Details HRMY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.11M Sell
30,608
-17,675
-37% -$558K ﹤0.01% 1938
2026
Q1 		$1.35M Sell
48,283
-12,250
-20% -$402K ﹤0.01% 1696
2025
Q4 		$2.27M Buy
60,533
+44,477
+277% +$1.46M ﹤0.01% 1321
2025
Q3 		$443K Buy
+16,056
New +$553K ﹤0.01% 2055

Other funds holding HRMY

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
LSV Asset Management
LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Cerity Partners's HRMY Position: Q2 2026 in Review

Cerity Partners reduced its Harmony Biosciences (HRMY) stake by 37% in Q2 2026, selling an estimated $558K and leaving 30,608 shares worth $1.11M. The position accounts for ﹤0.01% of the portfolio, ranked #1938.

Cerity Partners first reported a position in HRMY in Q3 2025 and has held it in 4 quarters since. The position peaked at $2.27M in Q4 2025. 327 funds tracked by Wall St. Rank hold HRMY as of Q2 2026.

  • Cerity Partners held 30,608 shares of Harmony Biosciences worth $1.11M as of Q2 2026.
  • Cerity Partners sold 17,675 Harmony Biosciences shares in Q2 2026, an estimated $558K.
  • Harmony Biosciences made up ﹤0.01% of Cerity Partners's portfolio in Q2 2026, its #1938 holding.
  • Cerity Partners first reported a position in Harmony Biosciences in Q3 2025 and has held it in 4 quarters since.
  • Cerity Partners's Harmony Biosciences position peaked at $2.27M in Q4 2025.
  • 327 funds tracked by Wall St. Rank held Harmony Biosciences as of Q2 2026.

Based on Cerity Partners's 13F filing for Q2 2026, filed 14 Aug 2026.